Searchable abstracts of presentations at key conferences in endocrinology

ea0035p925 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Conservative management of pituitary apoplexy – own experience

Styk Andrzej , Zielinski Grzegorz , Witek Przemyslaw , Koziarski Andrzej

Introduction: Pituitary apoplexy is a life-threatening entity developing as a result of ischemia or hemorrhage into pre-existing pituitary tumor. Clinical course is characteristic and commonly consists of severe headache accompanied by nausea, emesis, impaired consciousness, visual field impairment as well as eyeballs movement restriction. Symptoms are typically accompanied by secondary adrenal insufficiency. Corticosteroids are drugs of choice regarding coexisting adrenal ins...

ea0063p1054 | Pituitary and Neuroendocrinology 3 | ECE2019

Prolactinomas in women: clinical, neuroradiological and pathological predictive factors for efficacy of transphenoidal surgery

Witek Przemyslaw , Ozdarski Marcin , Maksymowicz Maria , Styk Andrzej , Szamotulska Katarzyna , Zielinski Grzegorz

Background: The treatment of choice in prolactinomas are dopamine agonists, with surgery reserved for cases refractory to or poorly tolerant of pharmacotherapy. Little is known on the associations between clinical, neuroradiological and pathological features influencing the efficacy of transphenoidal surgery.The Aim: To evaluate clinical, neuroradiological and neuropathological aspects of surgically treated prolactinomas in women, with a particular empha...

ea0070aep693 | Pituitary and Neuroendocrinology | ECE2020

Analysis of the value of bilateral inferior petrosal sinus sampling in the diagnosis and treatment of Cushing’s disease in patients with a negative or inconclusive result of magnetic resonance imaging

Styk Andrzej , Zięcina Piotr , Piasecki Piotr , Brzozowski Krzysztof , Witek Przemysław , Narloch Jerzy , Wierzbicki Marek , Zieliński Grzegorz

Diagnosis and treatment of Cushing’s disease is one of the greatest challenges of modern endocrinology. This is related to the fact that pituitary corticotropinomas are small tumours that are difficult to visualize in magnetic resonance imaging (MR). In about 40% of patients with Cushing’s disease, MR scans of the pituitary gland do not reveal any changes. The method that allows to localize the source of adrenocorticotropin (ACTH) secretion is bilateral inferior pe...

ea0063gp11 | Adrenal and Neuroendocrine - Tumour | ECE2019

Corticotropinoma as the underlying cause of intermittent Cushing’s syndrome in a patient previously diagnosed with primary pigmented adrenocortical disease (PPNAD) – a case report

Łebek-Szatańska Agnieszka , Stelmachowska-Banaś Maria , Zieliński Grzegorz , Zgliczyński Wojciech , Nowak Karolina M. , Styk Andrzej , Maksymowicz Maria , Roszkowska-Purska Katarzyna , Papierska Lucyna

Background: The diagnostic process to unveil the underlying cause of endogenous Cushing’s syndrome (CS) is often challenging. Sometimes, atypical manifestation of the disease or only periodic hypercortisolaemia with spontaneous resolutions are observed and make the diagnosis even more difficult. Although it is common in primary pigmented nodular adrenocortical disease (PPNAD), pituitary corticotroph adenoma can manifest itself as cyclic Cushing’s syndrome as well.</p...